Patent Rights and Competition: FTC Challenges J&J Case as Turkish Court Clarifies Pharma Patent Boundaries
Jun 25, 2026
The US FTC is challenging a court ruling involving Johnson & Johnson's patent acquisition for Stelara, arguing it could weaken antitrust enforcement in pharma. Separately, Turkey's Court of Cassation ruled that patent holders who file infringement actions and send warning letters to third parties are exercising lawful patent rights, dismissing an unfair competition claim by a generic company.